Cognyte Software Ltd.
(NASDAQ: CGNT)

Cogentix Medical, Inc. (Cogentix Medical), formerly Vision-Sciences Inc., is a medical device company. The Company is engaged in the design, development, manufacturing and marketing of products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, known as EndoSheath technology, providing users with endoscope turnover. The Company's products include Urgent PC Neuromodulation System, Macroplastique Bulking Agent, Endoscopy Systems and EndoSheath Technology. The Company is also engaged in the commercialization of the Urgent PC Neuromodulation System, a device which delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). Its Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). The Company offers 5000 and 7000 series of endoscopes, which are video endoscopy systems.

9.960

+0.160 (+1.63%)
Range 9.755 - 10.090   (3.43%)
Open 10.000
Previous Close 9.800
Bid Price 4.250
Bid Volume 10
Ask Price 4.590
Ask Volume 8
Volume 186,507
Value -
Remark
Delayed prices. Updated at 13 May 2025 04:00.
Data powered by
View All Events

About Cognyte Sftw

Cogentix Medical, Inc. (Cogentix Medical), formerly Vision-Sciences Inc., is a medical device company. The Company is engaged in the design, development, manufacturing and marketing of products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial b...
more

Share your investing ideas
Please login to view stock data and analysis